Skip to main content
SpringerLink
Log in

Everolimus shortens survival of newly diagnosed glioblastoma patients

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chinnaiyan P, Won M, Wen PY et al (2018) A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913. Neuro-Oncol 20(5):666–673

    Article  CAS  PubMed  Google Scholar 

  2. Wong ET, Lok E, Gautam S, Swanson KD (2015) Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer 113(2):232–241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Pitter KL, Tamagno I, Alikhanyan K et al (2016) Corticosteroids compromise survival in glioblastoma. Brain 139(5):1458–1471

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA

    Eric T. Wong & Kenneth D. Swanson

Authors
  1. Eric T. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth D. Swanson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric T. Wong.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, E.T., Swanson, K.D. Everolimus shortens survival of newly diagnosed glioblastoma patients. J Neurooncol 140, 179–180 (2018). https://doi.org/10.1007/s11060-018-2937-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-018-2937-y

Search

Navigation